Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?

J Am Coll Cardiol. 2010 May 25;55(21):2343-5. doi: 10.1016/j.jacc.2010.01.046.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Editorial

MeSH terms

  • Acetanilides / pharmacology*
  • Acetanilides / therapeutic use
  • Anti-Arrhythmia Agents / pharmacology*
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy
  • Cells, Cultured
  • Drug Delivery Systems
  • Female
  • Heart Atria / cytology
  • Heart Atria / drug effects
  • Humans
  • Male
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / physiology
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use
  • Ranolazine
  • Risk Assessment
  • Sampling Studies
  • Sensitivity and Specificity
  • Sodium Channels / drug effects*
  • Sodium Channels / metabolism

Substances

  • Acetanilides
  • Anti-Arrhythmia Agents
  • Piperazines
  • Sodium Channels
  • Ranolazine